ANGO
AngioDynamics, Inc. · Healthcare · Medical - Instruments & Supplies
Momentum inputs (comparable managers):
holder breadth +18.2% ·
share flow -8.8% ·
net new positions +15.4%
· formula
Ownership fragmentation: more holders, smaller aggregate stake
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q1 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 3 | -1 | 44.02K | $609,566 | n/a | −1 |
| Q2 2026 | 72 | +3 | 20.49M | $266.54M | +7 | −4 |
| Q1 2026 | 71 | -1 | 21.06M | $239.47M | +4 | −5 |
| Q4 2025 | 72 | 0 | 22.40M | $287.62M | +1 | −1 |
| Q3 2025 | 18 | 0 | 15.02M | $167.73M | n/a | n/a |
| Q2 2025 | 15 | -1 | 13.76M | $136.51M | n/a | −1 |
| Q1 2025 | 13 | +2 | 6.65M | $62.49M | +2 | n/a |
| Q4 2024 | 11 | 0 | 7.29M | $66.82M | n/a | n/a |
| Q3 2024 | 10 | 0 | 5.47M | $42.55M | n/a | n/a |
| Q2 2024 | 10 | n/a | 5.27M | $31.86M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Millennium Management ✦ | 1.24M | -42.7% | $11.64M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 2 | Geode Capital Management ✦ (passive) | 986.72K | +1.3% | $9.27M | 0.0% | ▲ Add | 4 | SEC ↗ ×2 |
| 3 | Point72 Asset Management ✦ | 928.66K | New | $8.72M | 0.0% | New | 1 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 895.93K | -1.9% | $8.41M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 5 | State Street Global Advisors ✦ (passive) | 839.56K | +0.7% | $7.88M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 6 | Arrowstreet Capital ✦ | 540.10K | +53.2% | $5.07M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | Marshall Wace ✦ | 428.07K | -10.2% | $4.02M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 8 | D. E. Shaw & Co. ✦ | 230.91K | -6.5% | $2.17M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 9 | Citadel Advisors ✦ | 202.92K | -75.1% | $1.91M | 0.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 10 | Two Sigma Investments ✦ | 127.45K | -59.9% | $1.20M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 11 | Adage Capital Partners ✦ | 100.00K | New | $939,000 | 0.0% | New | 1 | SEC ↗ |
| 12 | AQR Capital Management ✦ | 96.34K | -41.2% | $904,595 | 0.0% | ▼ Trim | 4 | SEC ↗ ×4 |
| 13 | T. Rowe Price ✦ | 38.45K | +4.1% | $362,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| Point72 Asset Management | $8.72M | 0.0% |
| Adage Capital Partners | $939,000 | 0.0% |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 145 holders, 38.52M shares, $430.26M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.